Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201

PHASE2TerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

October 31, 2005

Conditions
Hepatitis B
Interventions
DRUG

Clevudine

Trial Locations (7)

Unknown

Korea University Guro Hospital, Seoul

Seoul National University Hospital, Seoul

Yongdong Severance Hospital, Dogok-dong, Kangnam-gu

Samsung Medical Center, Ilwon-dong, Songpa-gu

Ehwa Womans University Mokdong Hospital, Mok-dong, Yangcheon-gu

Seoul Asan Medical Center, Pungnap-dong, Kangnam-gu

Asan Medical Center, P’ungnabi-dong

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT00362700 - Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201 | Biotech Hunter | Biotech Hunter